Below are the most recent publications written about "Caveolin 1" by people in Profiles.
-
Vasquez Rodriguez SY, Lazaridis T. Simulations suggest a scaffolding mechanism of membrane deformation by the caveolin 8S complex. Biophys J. 2023 10 17; 122(20):4082-4090.
-
Mart?nez M, Mart?nez NA, Miranda JD, Maldonado HM, Silva Ortiz WI. Caveolin-1 Regulates P2Y2 Receptor Signaling during Mechanical Injury in Human 1321N1 Astrocytoma. Biomolecules. 2019 10 18; 9(10).
-
Martinez NA, Ayala AM, Martinez M, Martinez-Rivera FJ, Miranda JD, Silva WI. Caveolin-1 Regulates the P2Y2 Receptor Signaling in Human 1321N1 Astrocytoma Cells. J Biol Chem. 2016 Jun 03; 291(23):12208-22.
-
Oyola-Cintr?n J, Caballero-Rivera D, Ballester L, Ba?z-Pag?n CA, Mart?nez HL, V?lez-Arroyo KP, Quesada O, Lasalde-Dominicci JA. Lateral diffusion, function, and expression of the slow channel congenital myasthenia syndrome aC418W nicotinic receptor mutation with changes in lipid raft components. J Biol Chem. 2015 Oct 30; 290(44):26790-800.
-
Biswas SK, Brako L, Lo WK. Massive formation of square array junctions dramatically alters cell shape but does not cause lens opacity in the cav1-KO mice. Exp Eye Res. 2014 Aug; 125:9-19.
-
Maurya VK, Sangappa C, Kumar V, Mahfooz S, Singh A, Rajender S, Jha RK. Expression and activity of Rac1 is negatively affected in the dehydroepiandrosterone induced polycystic ovary of mouse. J Ovarian Res. 2014 Mar 14; 7:32.
-
Zeng Y, Tarbell JM. The adaptive remodeling of endothelial glycocalyx in response to fluid shear stress. PLoS One. 2014; 9(1):e86249.
-
Sherif ZA, Sultan AS. Divergent control of Cav-1 expression in non-cancerous Li-Fraumeni syndrome and human cancer cell lines. Cancer Biol Ther. 2013 Jan; 14(1):29-38.
-
Bocci G, Fioravanti A, Orlandi P, Di Desidero T, Natale G, Fanelli G, Viacava P, Naccarato AG, Francia G, Danesi R. Metronomic ceramide analogs inhibit angiogenesis in pancreatic cancer through up-regulation of caveolin-1 and thrombospondin-1 and down-regulation of cyclin D1. Neoplasia. 2012 Sep; 14(9):833-45.
-
Omtri RS, Davidson MW, Arumugam B, Poduslo JF, Kandimalla KK. Differences in the cellular uptake and intracellular itineraries of amyloid beta proteins 40 and 42: ramifications for the Alzheimer's drug discovery. Mol Pharm. 2012 Jul 02; 9(7):1887-97.